| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
23,295 |
21,778 |
$752K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
23,230 |
21,713 |
$664K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
20,630 |
19,181 |
$619K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,829 |
6,559 |
$536K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
24,035 |
22,972 |
$402K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13,836 |
12,921 |
$366K |
| 87482 |
|
7,051 |
6,559 |
$336K |
| 87481 |
|
10,663 |
6,435 |
$297K |
| 87512 |
|
7,495 |
6,986 |
$274K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,121 |
2,876 |
$272K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,753 |
3,798 |
$206K |
| 87653 |
|
5,867 |
5,692 |
$195K |
| 87511 |
|
5,056 |
4,826 |
$167K |
| 87799 |
|
2,358 |
2,185 |
$82K |
| 87081 |
|
6,544 |
6,337 |
$52K |
| 88141 |
|
3,162 |
3,035 |
$47K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
775 |
615 |
$34K |
| 87625 |
|
528 |
513 |
$21K |
| 87150 |
|
619 |
603 |
$20K |
| 87529 |
|
457 |
215 |
$15K |
| 86769 |
|
289 |
283 |
$12K |
| 88185 |
|
29 |
25 |
$10K |
| 88275 |
|
55 |
51 |
$8K |
| 88342 |
|
203 |
194 |
$8K |
| 88271 |
|
55 |
51 |
$3K |
| 88304 |
|
42 |
42 |
$1K |
| 88184 |
|
29 |
25 |
$911.93 |
| 88313 |
|
42 |
37 |
$679.57 |
| 88291 |
|
43 |
39 |
$596.84 |
| 88341 |
|
16 |
12 |
$477.52 |
| 85060 |
|
28 |
28 |
$439.02 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
42 |
42 |
$362.50 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
48 |
37 |
$250.00 |
| 88311 |
|
41 |
37 |
$210.25 |